Vanguard Group’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.7M | Buy |
2,375,589
+86,066
| +4% | +$276K | ﹤0.01% | 3277 |
|
|
2025
Q3 | $6.66M | Buy |
2,289,523
+119,451
| +6% | +$275K | ﹤0.01% | 3176 |
|
|
2025
Q2 | $3.93M | Sell |
2,170,072
-272,235
| -11% | -$484K | ﹤0.01% | 3294 |
|
|
2025
Q1 | $3.66M | Sell |
2,442,307
-71,178
| -3% | -$180K | ﹤0.01% | 3283 |
|
|
2024
Q4 | $5.93M | Sell |
2,513,485
-9,313
| -0.4% | -$164K | ﹤0.01% | 3202 |
|
|
2024
Q3 | $74.2M | Sell |
2,522,798
-160,328
| -6% | -$3.69M | ﹤0.01% | 2014 |
|
|
2024
Q2 | $33.1M | Buy |
2,683,126
+326,646
| +14% | +$6.89M | ﹤0.01% | 2319 |
|
|
2024
Q1 | $47.8M | Buy |
2,356,480
+31,854
| +1% | +$734K | ﹤0.01% | 2190 |
|
|
2023
Q4 | $52.3M | Buy |
2,324,626
+56,060
| +2% | +$1.18M | ﹤0.01% | 2169 |
|
|
2023
Q3 | $37.7M | Buy |
2,268,566
+18,907
| +0.8% | +$375K | ﹤0.01% | 2259 |
|
|
2023
Q2 | $55.2M | Buy |
2,249,659
+12,754
| +0.6% | +$307K | ﹤0.01% | 2141 |
|
|
2023
Q1 | $54M | Buy |
2,236,905
+39,980
| +2% | +$1.11M | ﹤0.01% | 2143 |
|
|
2022
Q4 | $64.9M | Buy |
2,196,925
+87,062
| +4% | +$3.13M | ﹤0.01% | 2038 |
|
|
2022
Q3 | $88.2M | Buy |
2,109,863
+62,151
| +3% | +$1.68M | ﹤0.01% | 1869 |
|
|
2022
Q2 | $57.6M | Buy |
2,047,712
+72,983
| +4% | +$1.84M | ﹤0.01% | 2130 |
|
|
2022
Q1 | $73.3M | Sell |
1,974,729
-86,090
| -4% | -$3.65M | ﹤0.01% | 2108 |
|
|
2021
Q4 | $90.1M | Buy |
2,060,819
+86,537
| +4% | +$4.54M | ﹤0.01% | 2045 |
|
|
2021
Q3 | $123M | Buy |
1,974,282
+148,079
| +8% | +$12.4M | ﹤0.01% | 1871 |
|
|
2021
Q2 | $156M | Buy |
1,826,203
+52,025
| +3% | +$2.79M | ﹤0.01% | 1760 |
|
|
2021
Q1 | $79.7M | Buy |
1,774,178
+190,315
| +12% | +$7.49M | ﹤0.01% | 2072 |
|
|
2020
Q4 | $10.8M | Buy |
1,583,863
+310,462
| +24% | +$2.77M | ﹤0.01% | 2955 |
|
|
2020
Q3 | $14.7M | Buy |
1,273,401
+152,191
| +14% | +$686K | ﹤0.01% | 2597 |
|
|
2020
Q2 | $3.45M | Buy |
1,121,210
+287,169
| +34% | +$1.3M | ﹤0.01% | 3257 |
|
|
2020
Q1 | $3.43M | Buy |
834,041
+653,188
| +361% | +$4.32M | ﹤0.01% | 3131 |
|
|
2019
Q4 | $940K | Buy |
180,853
+6,178
| +4% | +$10.7K | ﹤0.01% | 3659 |
|
|
2019
Q3 | $210K | Buy |
174,675
+7,613
| +5% | +$9.78K | ﹤0.01% | 3953 |
|
|
2019
Q2 | $202K | Sell |
167,062
-8,280
| -5% | -$9.39K | ﹤0.01% | 3975 |
|
|
2019
Q1 | $226K | Buy |
175,342
+29,818
| +20% | +$34.2K | ﹤0.01% | 3901 |
|
|
2018
Q4 | $124K | Sell |
145,524
-73,326
| -34% | -$84.3K | ﹤0.01% | 3972 |
|
|
2018
Q3 | $221K | Buy |
218,850
+37,466
| +21% | +$56.9K | ﹤0.01% | 3991 |
|
|
2018
Q2 | $373K | Hold |
181,384
| – | – | ﹤0.01% | 3874 |
|
|
2018
Q1 | $1.29M | Buy |
181,384
+9,417
| +5% | +$63.6K | ﹤0.01% | 3592 |
|
|
2017
Q4 | $688K | Sell |
171,967
-11,921
| -6% | -$48.1K | ﹤0.01% | 3688 |
|
|
2017
Q3 | $748K | Sell |
183,888
-4,167
| -2% | -$14.9K | ﹤0.01% | 3666 |
|
|
2017
Q2 | $774K | Sell |
188,055
-42,957
| -19% | -$203K | ﹤0.01% | 3632 |
|
|
2017
Q1 | $1.45M | Hold |
231,012
| – | – | ﹤0.01% | 3477 |
|
|
2016
Q4 | $922K | Sell |
231,012
-30,196
| -12% | -$140K | ﹤0.01% | 3581 |
|
|
2016
Q3 | $1.83M | Buy |
261,208
+53,443
| +26% | +$886K | ﹤0.01% | 3421 |
|
|
2016
Q2 | $3.19M | Buy |
207,765
+6,686
| +3% | +$106K | ﹤0.01% | 3191 |
|
|
2016
Q1 | $3.14M | Buy |
201,079
+2,680
| +1% | +$34.7K | ﹤0.01% | 3193 |
|
|
2015
Q4 | $2.43M | Buy |
198,399
+3,363
| +2% | +$44.5K | ﹤0.01% | 3314 |
|
|
2015
Q3 | $2.5M | Buy |
195,036
+5,085
| +3% | +$64.2K | ﹤0.01% | 3272 |
|
|
2015
Q2 | $2.3M | Sell |
189,951
-4,366
| -2% | -$59.8K | ﹤0.01% | 3349 |
|
|
2015
Q1 | $2.57M | Buy |
194,317
+8,412
| +5% | +$114K | ﹤0.01% | 3303 |
|
|
2014
Q4 | $2.64M | Buy |
185,905
+2,328
| +1% | +$40.3K | ﹤0.01% | 3180 |
|
|
2014
Q3 | $5.03M | Buy |
183,577
+6,810
| +4% | +$207K | ﹤0.01% | 2822 |
|
|
2014
Q2 | $7.11M | Buy |
176,767
+10,652
| +6% | +$394K | ﹤0.01% | 2672 |
|
|
2014
Q1 | $6.4M | Buy |
166,115
+5,316
| +3% | +$188K | ﹤0.01% | 2707 |
|
|
2013
Q4 | $5.47M | Buy |
160,799
+4,629
| +3% | +$123K | ﹤0.01% | 2749 |
|
|
2013
Q3 | $2.97M | Buy |
156,170
+3,178
| +2% | +$55.6K | ﹤0.01% | 2979 |
|
|
2013
Q2 | $2.37M | Buy |
+152,992
| New | +$3.23M | ﹤0.01% | 3005 |
|
Other funds holding FLNA
GCP
Vanguard Group's FLNA Position: Q4 2025 in Review
Vanguard Group increased its Filana Therapeutics (FLNA) stake by 3.8% in Q4 2025, buying an estimated $276K and bringing the position to 2,375,589 shares worth $4.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3277.
Vanguard Group first reported a position in FLNA in Q2 2013 and has held it in 51 quarters since. The position peaked at $156M in Q2 2021. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.
- Vanguard Group held 2,375,589 shares of Filana Therapeutics worth $4.7M as of Q4 2025.
- Vanguard Group bought 86,066 Filana Therapeutics shares in Q4 2025, an estimated $276K.
- Filana Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3277 holding.
- Vanguard Group first reported a position in Filana Therapeutics in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Filana Therapeutics position peaked at $156M in Q2 2021.
- 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.